Organization
Medicines for Malaria Venture
9 clinical trials
Clinical trial
An Open Label Phase 1b Study to Characterise the Pharmacokinetic/Pharmacodynamic Relationship and Safety of MMV367 in Healthy Adult Participants Experimentally Infected With Blood Stage Plasmodium FalciparumStatus: Completed, Estimated PCD: 2023-10-30
Clinical trial
Phase 1, Open-label, Cross-over Study to Investigate the Relative Bioavailability of Pyramax (Pyronaridine-artesunate) in Tablet and Granule Formulations, in Healthy VolunteersStatus: Completed, Estimated PCD: 2013-10-01
Clinical trial
Open-label, Drug Interaction Study of Pyronaridine-artesunate and Metoprolol in Healthy Volunteers and Pyronaridine-artesunate Redosing Study in Healthy VolunteersStatus: Completed, Estimated PCD: 2012-07-01
Clinical trial
A Randomized, Open Label, Two-part, Parallel-group, Phase I Study to Evaluate the Pharmacokinetics of Piperaquine Oral Dispersible Granules Formulation Compared to Piperaquine Hard Tablets Administered as a Single Dose in Fasting Condition (Part 1) and of Piperaquine Oral Dispersible Granules Formulation Administered as Single Dose in Various Fed States (Part 2) in Healthy Adult ParticipantsStatus: Completed, Estimated PCD: 2023-12-06
Clinical trial
Health Care Provider Use of Plasmodium Vivax Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in PeruStatus: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
Phase 1b to Assess Safety, Tolerability, Pharmacokinetic Profile, and Antimalarial Activity of Single Doses of Co-administered OZ439and PQP Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2019-04-19
Clinical trial
Open-label, Randomised, Drug Interaction Study of Pyramax (Pyronaridine Artesunate) and the Protease Inhibitor Ritonavir in Healthy VolunteersStatus: Completed, Estimated PCD: 2010-08-01
Clinical trial
Phase I, Randomized, Single Dose, Bioequivalence Trial of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference TabletStatus: Completed, Estimated PCD: 2008-07-01
Clinical trial
A Randomised, Double-blind, Placebo Controlled, Parallel Group Study in Healthy Adult Volunteers to Determine the Tolerability and Safety of Pyronaridine (PYR) Co-administered With Piperaquine (PQP) Under Fasted ConditionsStatus: Completed, Estimated PCD: 2022-05-31